A phase III, multicenter, Open-label, Randomized trial in previously untreated patients with CD20-positive advanced indolent non-Hodgkin's lymphoma

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2011
This article has no abstract
Epistemonikos ID: 88392107842b9e99a64b412d07fb2dc756e5c278
First added on: Apr 16, 2025